Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B virus-induced oncogenesis.

Joachim Lupberger1, Eberhard Hildt

  • 1University of Freiburg, Department of Internal Medicine II, Hugstetter Strasse 55, Freiburg D-79106, Germany.

World Journal of Gastroenterology
|January 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.

Science translational medicine·2026
Same author

Hepatitis D Virus Pathogenesis: A Sense of Complications.

Viruses·2026
Same author

Higher prevalence of cytomegalovirus and Epstein-Barr virus in acute-on-chronic liver failure.

JHEP reports : innovation in hepatology·2026
Same author

Chemoprevention of hepatocellular carcinoma by next-generation antipsychotic aripiprazole.

Hepatology (Baltimore, Md.)·2026
Same author

HDV sensing drives USP18-mediated refractoriness to IFN-α response, sparing IFN-β/λ in hepatocytes.

Antiviral research·2026
Same author

Isochlorogenic acid A impairs hepatitis B virus replication by interference with various steps of hepatitis B virus life cycle involving HO-1-mediated ROS modulation.

Antiviral research·2025
Same journal

Lessons from extended induction and practical evidence for improving tofacitinib therapy in ulcerative colitis.

World journal of gastroenterology·2026
Same journal

Small animal <i>ex vivo</i> machine perfusion of the liver: A comprehensive literature review.

World journal of gastroenterology·2026
Same journal

Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics <i>vs</i> biosimilars.

World journal of gastroenterology·2026
Same journal

Diagnosis and management of metabolic dysfunction-associated steatohepatitis in patients with chronic hepatitis B infection.

World journal of gastroenterology·2026
Same journal

Simultaneous treatment of concomitant achalasia coexisting with epiphrenic diverticulum: The practice of submucosal tunneling technique.

World journal of gastroenterology·2026
Same journal

Lianhe Xiaozhi ointment ameliorates metabolic dysfunction-associated steatotic liver disease <i>via</i> peroxisome proliferator-activated receptor alpha pathway activation.

World journal of gastroenterology·2026
See all related articles

Hepatitis B virus (HBV) infection significantly increases hepatocellular carcinoma (HCC) risk through direct DNA integration and chronic inflammation. Understanding these mechanisms is key for new HCC diagnosis and therapies.

Area of Science:

  • Hepatology
  • Oncology
  • Virology

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent cancer with rising incidence globally.
  • Hepatitis B virus (HBV) is linked to approximately 53% of worldwide HCC cases.
  • HBV infection elevates HCC risk by 25-37 times in HBsAg carriers.

Purpose of the Study:

  • To elucidate the multifactorial mechanisms of HBV-associated carcinogenesis.
  • To explore the roles of direct and indirect pathways in tumor development.
  • To identify potential targets for novel HCC diagnosis and therapy.

Main Methods:

  • Review of epidemiological data and molecular studies on HBV and HCC.
  • Analysis of HBV DNA integration and its impact on host genes (insertional mutagenesis).

Related Experiment Videos

  • Investigation of chronic liver inflammation, cell regeneration, and oncogenic protein functions (HBx, PreS2).

    • Main Results:

    • HBV DNA integration into the host genome is an early event in tumor development.
    • Integration can disrupt cancer-related genes, leading to mutagenesis.
    • Chronic inflammation and viral proteins (HBx, PreS2) promote tumor progression.

    Conclusions:

    • HBV-associated carcinogenesis involves synergistic direct and indirect mechanisms.
    • Understanding molecular pathways can lead to improved diagnostic and therapeutic strategies for HCC.
    • Gene expression profiling and proteomics offer insights into HBV-driven cancer mechanisms.